Foretinib is a quinoline substituted by 2-fluoro-4-[({1-[(4-fluorophenyl)carbamoyl]cyclopropyl}carbonyl)amino]phenoxy, methoxy, and 3-(morpholin-4-yl)propoxy groups at positions 4, 6 and 7, respectively. It is a multi-kinase inhibitor. It has a role as an antineoplastic agent, a vascular endothelial growth factor receptor antagonist, an apoptosis inducer and a c-Met tyrosine kinase inhibitor. It is a member of quinolines, an aromatic ether, a dicarboxylic acid diamide, a member of morpholines, a member of cyclopropanes and a member of monofluorobenzenes.
